InBioGen Co Ltd (101140) — Financial Flexibility Index

Latest as of September 2025: -0.68x

InBioGen Co Ltd (101140) has a Financial Flexibility Index of -0.68x as of September 2025. Free cash flow of ₩-1.66 Billion (operating CF ₩-1.67 Billion minus capex ₩4.10 Million) represents -1% of total liabilities (₩2.44 Billion). Check 101140 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Financial Flexibility Index

-0.68x
Free Cash Flow / Total Liabilities

Free Cash Flow

₩-1.66 Billion
Operating CF − Capex

Total Liabilities

₩2.44 Billion
KRW

Capital Expenditures

₩4.10 Million
KRW

InBioGen Co Ltd Financial Flexibility Index (2013–2024)

Historical Financial Flexibility Index trend for InBioGen Co Ltd across 12 annual periods. For the full cash flow conversion analysis, see 101140 cash flow metrics.

Annual Financial Flexibility Index for InBioGen Co Ltd (2013–2024)

Year-by-year free cash flow to debt coverage for InBioGen Co Ltd. Explore InBioGen Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (KRW) Operating CF Total Liabilities YoY Change
2024 0.02x ₩51.15 Million ₩-33.13 Million ₩2.89 Billion ▲ +106.4%
2023 -0.27x ₩-719.73 Million ₩-1.05 Billion ₩2.62 Billion ▲ +9.7%
2022 -0.30x ₩-11.37 Billion ₩-11.51 Billion ₩37.40 Billion ▼ -523.0%
2021 -0.05x ₩-4.71 Billion ₩-7.07 Billion ₩96.45 Billion ▲ +87.8%
2020 -0.40x ₩-7.60 Billion ₩-8.03 Billion ₩18.97 Billion ▼ -182.2%
2019 -0.14x ₩-3.54 Billion ₩-3.83 Billion ₩24.92 Billion ▲ +90.2%
2018 -1.46x ₩-1.41 Billion ₩-1.70 Billion ₩968.80 Million ▼ -2077.4%
2017 -0.07x ₩-138.08 Million ₩-426.44 Million ₩2.07 Billion ▼ -228.5%
2016 0.05x ₩344.75 Million ₩344.75 Million ₩6.62 Billion ▲ +103.3%
2015 -1.60x ₩-10.82 Billion ₩-10.96 Billion ₩6.76 Billion ▼ -611.5%
2014 -0.22x ₩-671.70 Million ₩-695.95 Million ₩2.99 Billion ▼ -37.8%
2013 -0.16x ₩-1.03 Billion ₩-1.13 Billion ₩6.33 Billion
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities